——深圳和美婦兒科醫院有限公司隸屬于和美醫療控股有限公司，15年7月7日在香港正式掛牌上市（港股代碼：），簡稱“和美醫療”，是中國最大的私立婦產專科醫院集團。深圳和美婦兒科醫院為海內外女性、兒童提供優質醫療服務和健康管理高品質、更安全的醫療機構。
 

 ——2011年10月，和美醫院首次通過國際醫療衛生機構聯合委員會（JCI）認證，成為深圳首家JCI認證的高端婦兒科醫院。2014年10月，醫院再次以高分通過第五版JCI認證復審。
 

 ——和美醫院采用與美國同步的醫療安全保障體系和治療系統，領先的醫療技術和管理模式幫助客戶獲得安全、綠色醫療。和美提倡以外用藥物、物理療法治療疾病，用行為醫學調理亞健康和慢性疾病，減少抗生素的使用，拒絕過度治療等醫療方式。
 

 Shenzhen HarMoniCare Women&Children's Hospital, affiliated with HarMoniCare Medical Holding Limited, is the largest private maternity hospital in China. On July 7,2015, the corporation was officially registered on the Hong Kong Stock Exchange (Hong Kong stock code ). Shenzhen HarMoniCare Women&Children's Hospital provides high-quality health care and health management services for women and children from China and abroad.
 

 In October,2011, HarMoniCare passed the initial accreditation survey by Joint Commission International(JCI), becoming the first JCI-accredited hospital in Shenzhen. In October,2014,HarMoniCare Shenzhen Women and Children's Hospital again sailed through the second accreditation survey besed on the newly-published fifth edition edition JCI standards with ——深圳和美婦兒科醫院有限公司隸屬于和美醫療控股有限公司，15年7月7日在香港正式掛牌上市（港股代碼：），簡稱“和美醫療”，是中國最大的私立婦產專科醫院集團。深圳和美婦兒科醫院為海內外女性、兒童提供優質醫療服務和健康管理高品質、更安全的醫療機構。
 

 ——2011年10月，和美醫院首次通過國際醫療衛生機構聯合委員會（JCI）認證，成為深圳首家JCI認證的高端婦兒科醫院。2014年10月，醫院再次以高分通過第五版JCI認證復審。
 

 ——和美醫院采用與美國同步的醫療安全保障體系和治療系統，領先的醫療技術和管理模式幫助客戶獲得安全、綠色醫療。和美提倡以外用藥物、物理療法治療疾病，用行為醫學調理亞健康和慢性疾病，減少抗生素的使用，拒絕過度治療等醫療方式。
 

 Shenzhen HarMoniCare Women&Children's Hospital, affiliated with HarMoniCare Medical Holding Limited, is the largest private maternity hospital in China. On July 7,2015, the corporation was officially registered on the Hong Kong Stock Exchange (Hong Kong stock code ). Shenzhen HarMoniCare Women&Children's Hospital provides high-quality health care and health management services for women and children from China and abroad.
 

 In October,2011, HarMoniCare passed the initial accreditation survey by Joint Commission International(JCI), becoming the first JCI-accredited hospital in Shenzhen. In October,2014,HarMoniCare Shenzhen Women and Children's Hospital again sailed through the second accreditation survey besed on the newly-published fifth edition edition JCI standards with flying colors.
 

 HarMoniCare Shenzhen Women and Children's Hospital adopts and advocates an American patient safety and care system, which is the world's leading model of medical technology and management, providing safe and green care for customers. HarMoniCare advocates treatment with topically-applied medication and physiotherapy treatment office disease, and improvement of patients' sub-health status and noncommunicable diseases through behavioral medical intervention. HarMoniCare strictly follows recommendations for the appropriate prescription of antibiotics and is committed to reducing overtreatment.